# HALT Progression of Polycystic Kidney Disease Study B

> **NCT01885559** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 486 (actual)

## Conditions studied

- Kidney, Polycystic

## Interventions

- **DRUG:** Lisinopril
- **DRUG:** Telmisartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01885559
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2020-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01885559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01885559, "HALT Progression of Polycystic Kidney Disease Study B". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01885559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*